Johnson & Johnson (JNJ.US) experimental Shockwave Javelin catheter technology achieves a 94% success rate, potentially expanding the market for complex coronary artery procedures
智通财经2026/11/02 03:00Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Zhihu Finance APP reported that Johnson & Johnson (JNJ.US) announced positive 30-day results last Sunday from its experimental Shockwave Javelin catheter clinical trial. This catheter is used to treat severely narrowed coronary arteries that are difficult to access with conventional devices.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$78,581.16
+1.23%
Ethereum
ETH
$2,306.63
+1.94%
Tether USDt
USDT
$0.9986
-0.01%
BNB
BNB
$713.09
+1.54%
XRP
XRP
$1.26
+0.84%
USDC
USDC
$0.9996
-0.01%
Solana
SOL
$95.39
+0.14%
TRON
TRX
$0.3138
+1.84%
Hyperliquid
HYPE
$88.49
+0.95%
Zcash
ZEC
$1,279.96
+3.19%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now